These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38928008)

  • 41. Mitochondrial mechanisms in Alzheimer's disease: Quest for therapeutics.
    Kalani K; Chaturvedi P; Chaturvedi P; Kumar Verma V; Lal N; Awasthi SK; Kalani A
    Drug Discov Today; 2023 May; 28(5):103547. PubMed ID: 36871845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism.
    Hroudová J; Singh N; Fišar Z; Ghosh KK
    Eur J Med Chem; 2016 Oct; 121():774-784. PubMed ID: 27094132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
    Yang Y; Jia X; Yang X; Wang J; Fang Y; Ying X; Zhang M; Wei J; Pan Y
    Brain Res; 2024 Jul; 1835():148920. PubMed ID: 38599511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.
    Wilkins HM; Swerdlow RH
    Curr Top Med Chem; 2016; 16(8):849-57. PubMed ID: 26311426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
    Dixit S; Fessel JP; Harrison FE
    Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
    Blass JP; Gibson GE
    Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.
    Wilkins HM; Morris JK
    Curr Pharm Des; 2017; 23(5):731-752. PubMed ID: 28034353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA.
    Mancuso M; Orsucci D; LoGerfo A; Calsolaro V; Siciliano G
    Adv Exp Med Biol; 2010; 685():34-44. PubMed ID: 20687493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?
    Macdonald R; Barnes K; Hastings C; Mortiboys H
    Biochem Soc Trans; 2018 Aug; 46(4):891-909. PubMed ID: 30026371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology.
    Moreira PI; Carvalho C; Zhu X; Smith MA; Perry G
    Biochim Biophys Acta; 2010 Jan; 1802(1):2-10. PubMed ID: 19853658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of mitochondrial genome abundance in Alzheimer's disease.
    Harerimana NV; Paliwali D; Romero-Molina C; Bennett DA; Pa J; Goate A; Swerdlow RH; Andrews SJ
    Alzheimers Dement; 2023 May; 19(5):2069-2083. PubMed ID: 36224040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alzheimer's disease pathogenesis: Is there a role for folate?
    Robinson N; Grabowski P; Rehman I
    Mech Ageing Dev; 2018 Sep; 174():86-94. PubMed ID: 29037490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nitric oxide links mitochondrial fission to Alzheimer's disease.
    Westermann B
    Sci Signal; 2009 May; 2(69):pe29. PubMed ID: 19417214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Tau Protein on Mitochondrial Functions.
    Epremyan KK; Goleva TN; Zvyagilskaya RA
    Biochemistry (Mosc); 2022 Aug; 87(8):689-701. PubMed ID: 36171651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alzheimer's as a metabolic disease.
    Demetrius LA; Driver J
    Biogerontology; 2013 Dec; 14(6):641-9. PubMed ID: 24249045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitoferrin-1 is Involved in the Progression of Alzheimer's Disease Through Targeting Mitochondrial Iron Metabolism in a Caenorhabditis elegans Model of Alzheimer's Disease.
    Huang J; Chen S; Hu L; Niu H; Sun Q; Li W; Tan G; Li J; Jin L; Lyu J; Zhou H
    Neuroscience; 2018 Aug; 385():90-101. PubMed ID: 29908215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
    Wang W; Zhao F; Ma X; Perry G; Zhu X
    Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease.
    Martín-Maestro P; Gargini R; García E; Perry G; Avila J; García-Escudero V
    Oxid Med Cell Longev; 2017; 2017():9302761. PubMed ID: 29201274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.